Nilotinib is a tyrosine kinase inhibitor that slows or stops the growth of certain types of cancer cells.
Nilotinib is a targeted cancer medicine that belongs to the class of tyrosine-kinase inhibitors. It is designed to block a specific protein that drives the growth of certain blood cancers. In Hong Kong, nilotinib is most commonly found in the branded product Tasigna.
The key product that contains nilotinib is Tasigna, which is available in tablet form in two strengths (usually 200 mg and 400 mg). Both strengths are marketed in Hong Kong and are approved by the Department of Health. A generic version of nilotinib may also be supplied, but it is less common in local pharmacies. Tasigna tablets are taken orally, and the medication may be supplied as a single-ingredient product or as part of a combination regimen prescribed by a specialist.
These cancers are driven by an abnormal enzyme that nilotinib blocks, slowing the growth of malignant cells and helping the bone-marrow to produce normal blood cells again. The medication is usually prescribed by haematology specialists after confirming the diagnosis through laboratory testing.
Nilotinib binds to the abnormal enzyme inside cancer cells, preventing it from sending growth signals. By turning off this signal, the drug slows or stops the uncontrolled multiplication of leukaemic cells. Because it targets a specific protein, nilotinib tends to affect only the malignant cells, leaving most normal cells unharmed. Patients typically notice the drug’s effect within weeks, although full benefits may develop over several months.
These reactions are usually temporary and may improve as the body adjusts to the medication.
If any of these signs appear, contact a health professional right away.
Always discuss personal health history with a specialist before starting treatment.
For a complete list of interactions, refer to the specific product’s information sheet.
Store Tasigna tablets at room temperature, away from moisture and direct sunlight. Keep them out of reach of children. Treatment duration can vary; some patients use nilotinib for many years under specialist supervision. Always follow the instructions that accompany your specific prescription, as formulations and dosing schedules differ between products. For detailed usage, dosing, and administration, refer to your specific medication's information.
Tyrosine-kinase inhibitor: A drug that blocks a protein enzyme involved in cell growth, used mainly in certain cancers.
QT interval: A measurement on an ECG that reflects heart rhythm; prolonged QT can increase the risk of serious arrhythmias.
Philadelphia chromosome: A genetic abnormality that creates the abnormal enzyme targeted by nilotinib.
This article offers general educational information about nilotinib as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing nilotinib may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.